Built from
What Was Missing
SymbAIo Inc. is a boutique technology company formed in October 2025 and incorporated as a Delaware C-Corp. Building adaptive intelligence for complex human experiences — health, safety, survival, and cognition. Our platforms read what your body already knows and put that understanding in your hands.
Our Mission
To build intelligence systems worthy of the humans they serve — technology that listens before it speaks, learns without extracting, and returns agency to the people it was made for.
Our Vision
A world where the relationship between people and technology is symbiotic — where AI amplifies human ingenuity, honors lived experience, and serves the full spectrum of who we are.
"We don't build technology that replaces human judgment.
We build technology intelligent enough to support it."
The Peaceful Confluence of Humanity & Intelligence
SymbAIo exists at the intersection of human ingenuity and system intelligence. We believe the AI revolution doesn't have to be a disruption — it can be a deepening. A return to what technology was always supposed to do: serve people.
Human-Led, Not AI-Driven
We don't say "AI-powered" because that puts the machine at the center. Our systems are human-led — AI is the instrument, not the conductor. The person always comes first.
Symbiotic by Design
Symbiosis means mutual benefit. Our platforms create a living feedback loop between human experience and system intelligence — each making the other more capable, more attuned, more useful.
Analog Meets Digital
The most meaningful data isn't born digital — it's lived. We honor the analog reality of human experience and build technology that bridges the gap between what you feel and what systems can understand.
Trauma-Informed by Architecture
Technology designed for survivors must be built differently. K@te™ is not an alerting system — it's an awareness system. It never sends signals to anyone but the user. It never creates data that can be weaponized. It never assumes it knows better than the person wearing it. These aren't features. They're foundational architectural decisions informed by the realities of psychological violence and coercive control.
Diversity, Equity & Inclusion
Technology That Reflects Who It Serves
SymbAIo is led by an intentionally diverse, all-female director-level team — not as a statement, but as a structural commitment. We believe that the people building technology should reflect the people using it. When the room where decisions are made looks like the world those decisions affect, the outcomes are fundamentally different.
Our commitment to DEI isn't a program or an initiative — it's architecture. We build for commonly overlooked communities: BIPOC patients navigating systems that weren't designed for them, neurodivergent individuals whose complexity is too often reduced to a diagnosis, people with disabilities whose accessibility needs are treated as edge cases rather than design requirements.
K@te™ exists because the people most affected by psychological violence — disproportionately women, BIPOC individuals, LGBTQ+ communities, and neurodivergent people — have been underserved by technology that treats "safety" as a button to press rather than a context to understand. We build for them first.
We are reconnecting technology with its human makers. Every product in the Signature Suite is designed to hold the full spectrum of human experience — not the simplified version that's easier to model, but the real, messy, beautiful complexity of actual lives.
100%
Female Director-Level Leadership
BIPOC
Founded & Led
Accessibility
First, Not Afterthought
Powered by mønk™ — Built with Claude by Anthropic
SymbAIo is an AI company. We don't shy away from that. But we believe the question isn't whether to use artificial intelligence — it's whose intelligence you trust to hold the complexity of a human life.
mønk™ is SymbAIo's proprietary intelligence engine — the architecture beneath every product we build. We chose Claude by Anthropic as our AI provider of choice to power mønk™. Not because it was the most convenient option. Because it was the most aligned one.
Anthropic builds AI with a commitment to safety, interpretability, and human benefit that mirrors our own design principles. Claude powers the custom AI tools we design for SymbAIo Labs clients — from iMpatient™ to enterprise engagements. When we say "human-led intelligence," we mean our systems support human judgment rather than replacing it. Anthropic's approach to AI development reflects that same conviction — building models that are honest, harmless, and helpful by design.
For a company processing sensitive biomarker data from people navigating chronic illness and psychological violence, the choice of AI partner is not a technical footnote. It's a trust decision. We chose the partner whose values match the gravity of what we're building.
Software We Love
We're deliberate about the tools we build with — just like we're deliberate about what we build. These are the platforms that power SymbAIo's daily work.
Claude
Our AI provider of choice. Claude by Anthropic powers mønk™, our proprietary intelligence engine, and every custom AI tool we build for SymbAIo Labs clients.
Manus
Our lab. Where we test theory, explore ideas, and stress-test what's possible before it becomes product.
Google Workspace
Our operating system. Docs, communication, and collaboration infrastructure for a globally distributed team.
Telegram
Our pulse. Fast, encrypted, real-time coordination for a team that never stops moving.
Azure Antoinette
Founder & CEO, SymbAIo Inc.
"Maya Angelou of the Millennial Generation" — Forbes
Commissioned Poet · Actress · TED Speaker
GRAMMY™ Considered Artist · DEI Advisor
Creator, iMpatient™
Azure Antoinette is a commissioned poet, actress, TED Speaker, GRAMMY™ Considered recording artist, international DEI corporate advisor, self-taught developer, and the Founder and CEO of SymbAIo Inc. Named the "Maya Angelou of the Millennial Generation" in Forbes' Most Powerful Women in the World Issue, Azure has spent nearly two decades transforming the intersection of storytelling, advocacy, and innovation into a force for systemic change.
Discovered in 2010 by Oprah Winfrey on the World Stage of the Minerva Conference, Azure has since shared stages across the globe with Elizabeth Gilbert and opened for Lady Gaga. In April 2021, she made television history on Grey's Anatomy as Irene Hayes — the first character to portray Multiple Sclerosis on screen while also representing the LGBT+ community. Her performance alongside co-star Kevin McKidd received GRAMMY™ consideration for their rendition of Snow Patrol's Chasing Cars.
A nearly 20-year survivor of Relapsing-Remitting Multiple Sclerosis, Azure draws on her lived experience navigating complex chronic conditions to fuel her work as a global patient advocate and healthcare innovator. She has served as a brand ambassador and keynote presenter for TED, SXSW, Genentech, Biogen, Johnson & Johnson, GLAAD, L'Oreal, The North Face, and many more.
Today, she is channeling two decades of advocacy, storytelling expertise, and personal resilience into building the future of patient-centered care. As a self-taught developer and the creator of iMpatient™ — powered by mønk™, a patent-pending pattern recognition engine — she is architecting the behavioral intelligence platform she needed but never had.
A Decade of Building at the Intersection
Before SymbAIo became a company, its ideas were shaped by nearly two decades of lived experience navigating complex systems — healthcare, entertainment, advocacy, and technology.
Azure Antoinette's career has spanned stages from the White House to TEDx, from recording studios to hospital wards. As a nearly 20-year MS survivor, she spent over a decade developing the patient-intelligence frameworks that would become iMpatient™. As a self-taught developer, she built the technical foundations of mønk™ from firsthand frustration with systems that reduce human complexity to data points.
SymbAIo's founding in October 2025 was not the beginning of the work. It was the moment the work became a company.
www.AzureAntoinette.comThe Team Behind the Signal
SymbAIo is led by an intentionally diverse, all-female director-level team — building technology that meets human needs by reflecting the full spectrum of human experience.
Azure Antoinette
Founder & CEO
Commissioned poet, TED Speaker, GRAMMY™ Considered artist, and nearly 20-year MS survivor. Creator of iMpatient™ and the driving vision behind SymbAIo's human-led intelligence philosophy
Cindy Gray
COO & Compliance
Leads operations, regulatory compliance, and organizational infrastructure. Ensures SymbAIo builds responsibly as it scales — from data governance to corporate operations
Jaidree Braddix
Head of Partnerships & Strategic Alignment
Brings deep partnership and capital strategy experience through Lingua Nova and D'accord Capital. Drives SymbAIo's strategic relationships, investor alignment, and ecosystem partnerships
Olivia Cardinali
Director of Community & Engagement
Owns SymbAIo's community strategy and user engagement. Building the relationships between the platform and the people it serves — patients, advocates, and early adopters
Sierra Gaskill
Jr. Project Manager, Community & K@te™ Outreach
Manages community operations and outreach initiatives for the K@te™ personal safety product. Coordinates cross-functional efforts between product and user communities
Jennifer Monge
Logistics Coordinator & Executive Admin to CEO
Provides executive operational support to the CEO and coordinates logistics across the organization. Keeps the founding team moving at pace
Interested in joining? Reach out at [email protected]
Built With Trusted Partners
The Signature Suite is built by our internal team in partnership with trusted engineering and development firms who share our standards for quality, privacy, and human-centered design.
Kite Union
Alexy Propenko — Senior Engineer
SymbAIo's core engineering partner. Kite Union leads platform architecture and systems development across the Signature Suite — building the technical infrastructure that powers mønk™, iMpatient™, and K@te™. Alexy leads the engineering team that brings SymbAIo's product vision to production.
Backable
Nigel Walton & TK
Strategic development partner supporting SymbAIo's growth infrastructure, founder positioning, and product-market readiness. Backable works at the intersection of startup strategy and technical execution.
Guided by Experience
IP Legal Counsel
Pandev Law
New York City
Advising SymbAIo on intellectual property strategy, patent filings, and IP protection across the Signature Suite — including the USPTO patent review for iMpulSIM™
Wearable Technology & Product
Gordy Bal
Former CIO, Oura
Former Chief Innovation Officer at Oura, the leading health wearable company. Advises on wearable data architecture, product-market fit, and health hardware ecosystem strategy
Rodrigo Catalan
Epson
Brings enterprise hardware and technology commercialization expertise from Epson. Advises on hardware-software integration and global technology distribution
Strategy, Innovation & Investment
Mark Bonchek
MIT & Epiphany Labs
Founder of Epiphany Labs and MIT-affiliated strategist specializing in platform thinking and digital transformation. Advises on platform strategy and ecosystem design
Emma Isaacs
VC & Angel Investment
Experienced venture and angel investor. Advises on fundraising strategy, investor relations, and capital alignment for SymbAIo's growth trajectory
Scott Augustin
Finance (Australia)
Financial strategy advisor. Supports SymbAIo's financial planning, modeling, and fiscal infrastructure as the company scales
Nigel Walton
Backable
Co-leads advisory through Backable, a firm focused on helping founders become investable. Advises on founder positioning, pitch strategy, and investor readiness
TK
Backable
Advises alongside Nigel Walton through Backable on startup development, storytelling, and strategic fundraising alignment
Martine Thurin JD
VP, Johnson & Johnson
Vice President at Johnson & Johnson with deep legal and corporate strategy expertise. Advises on regulatory navigation, corporate partnerships, and enterprise-scale health technology commercialization
Kaitlin Meiser
Johnson & Johnson
Brings pharmaceutical industry insight and operational expertise from Johnson & Johnson. Advises on health ecosystem partnerships, go-to-market strategy, and enterprise integration
Medical & Clinical
Dr. Mitzi Joi Williams
Neurologist & MS Specialist (USA)
Leading neurologist specializing in Multiple Sclerosis and health equity. Clinical advisor informing iMpatient™'s patient-first approach to correlative health intelligence
Dr. Marek Ciarcowski
Medical Advisor (Australia)
Provides clinical advisory perspective on health data systems and patient experience from the Australian healthcare landscape
Dr. Melissa Williams
Medical Advisor (Australia)
Advises on health technology, clinical validation, and the intersection of medical practice and patient-generated data
Sybill Carnocan
UCLA Geffen School of Medicine
Affiliated with UCLA's David Geffen School of Medicine. Brings academic medical research perspective to SymbAIo's health intelligence framework
Neurodiversity, Wellness & Human Complexity
Cherie Clonan
TDP, ASD & Neurodiversity Specialist
Founder of TDP and advocate for Autism Spectrum and neurodivergent communities. Advises on building inclusive, non-reductive intelligence systems that hold human complexity — ensuring SymbAIo's platforms serve neurodivergent users, who are disproportionately affected by both chronic illness and psychological violence
Caroline Brunne
Trauma & Vagus Nerve Alignment (Australia)
Specialist in trauma recovery and vagus nerve regulation. A critical advisor for K@te™ — bringing deep expertise in how the nervous system processes threat, stores trauma, and signals safety. Advises on the somatic intelligence that makes K@te™'s biomarker approach to survivor safety possible
Partners Across Industries
SymbAIo is built at the intersection of health, technology, safety, and human experience. Our partners reflect that breadth — spanning pharmaceutical innovation, enterprise technology, startup strategy, intellectual property, and community.
Johnson & Johnson
Global pharmaceutical and consumer health leader. Collaboration through patient advocacy, health innovation, and strategic advisory.
Google Workspace
Enterprise collaboration infrastructure. SymbAIo builds on Google's ecosystem for team operations and productivity.
Epson
Enterprise hardware and technology. Advisory partnership on hardware-software integration and global technology distribution.
Business Chicks
One of Australia's largest communities for entrepreneurial women. Aligned through founder networks and community-driven innovation.
The Digital Picnic (TDP)
Australia's leading neurodiversity and ASD workplace strategy company, founded by Cherie Clonan. Partnership on inclusive design, neurodivergent user experience, and building technology that holds human complexity without reducing it.
Backable
Startup development and investor-readiness firm. Strategic advisory on founder positioning, pitch strategy, and fundraising alignment.
Epiphany Labs
MIT-affiliated innovation strategy firm. Advisory partnership on platform thinking, digital transformation, and ecosystem design.
Pandev Law
IP legal counsel (New York City). Advising on intellectual property strategy, patent filings, and IP protection across the Signature Suite.
Zebras Medical
Australian health technology company. Collaboration on patient-centered health innovation.
Substack
Publishing and media platform. SymbAIo publishes its Insights and research through Substack, building in public.
Building across pharma, technology, community, law, and media.
Why This Doesn't Exist Yet
The wearable health market is booming — but the intelligence layer is missing. Current solutions fall into two camps: device manufacturers (Apple, Fitbit, Garmin) that collect data but don't interpret it contextually, and health platforms (Epic, Cerner, telehealth apps) that manage clinical workflows but ignore the patient's lived experience between visits.
SymbAIo sits in the gap between these worlds. We don't make devices. We don't replace health records. We build the intelligence layer that connects what your body is signaling to what your life actually looks like — and puts that understanding in your hands, not a system's.
The same gap exists in survivor safety. Current solutions — panic buttons, location sharing apps, GPS trackers — reduce safety to a binary: safe or in danger. They don't understand context. They don't read the body's own signals. And critically, they can be detected, disabled, or weaponized by abusers. K@te™ is designed for a reality that existing safety technology refuses to acknowledge: that psychological violence is invisible, that the body recognizes danger before the mind does, and that sovereignty — not surveillance — is the only architecture that serves survivors.
No existing platform offers patient-controlled, privacy-first correlative intelligence built from wearable biomarkers. That's not a feature gap. It's a category.
Mission & Values
"To build intelligence systems worthy of the humans they serve."
Human Sovereignty
Technology should amplify human agency, never diminish it. Every system we build returns control to the person it serves
Lived Experience as Design Input
The most valuable data isn't generated — it's lived. We build from real human complexity, not theoretical models
Privacy as Architecture
Privacy isn't a feature we add. It's the foundation we build on. Data sovereignty is structural, not optional
Clarity Over Prediction
We don't predict your future. We illuminate your present — helping you see patterns that were always there
Non-Reductive Intelligence
Human complexity is not a problem to solve. It's a reality to support. Our systems hold nuance without simplifying it away
Rigour Without Rigidity
We build with engineering precision and scientific discipline, but remain adaptive to the messiness of real life
Development Timeline
mønk™
BETAThe foundational operating layer powering the entire Signature Suite. Currently in BETA, driving test versions of iMpatient™ and K@te™
iMpatient™
TestingPatient-first health intelligence platform transforming wearable biomarker data into traceable, correlative blueprints. Launching May 30, 2026
K@te™
In DevelopmentPersonal safety companion that understands context, not just coordinates. Intelligent, non-intrusive protection. Launching November 2026
iMpulSIM™
USPTO Patent ReviewSignal processing engine identifying meaningful patterns in complex data streams. Early warning, not late reaction